SlideShare a Scribd company logo
1 of 79
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
CHAPTER 19
ANTIBIOTICS AND
ANTIMICROBIAL DRUGS
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
WHY IS THIS IMPORTANT?
 Antibiotics have drastically reduced the
number of deaths due to infection
 They have changed the face of health care
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
OVERVIEW
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SOURCE OF ANTIBIOTICS
 The discovery of the first antibiotic was an
accident
 Alexander Fleming accidentally contaminated a
plate with a fungus
 He observed a clearly defined region of no
bacterial growth where the fungi had contaminated
the plate
 The area around the fungus was eventually
referred to as a zone of inhibition
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SOURCE OF ANTIBIOTICS
 It is estimated that over 80 million
prescriptions are written in America each year
 12,500 tons of antibiotics are produced
annually
 From 1900 to 1980, mortality from infectious
diseases dropped from 797 per 100,000
persons to 36 per 100,000 persons
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
HISTORICAL PERSPECTIVES
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
HISTORICAL PERSPECTIVES
 Few major discoveries of natural antibiotic
substances have occurred for several years
 Efforts have now shifted to modifying existing
antibiotics
 Searching in new places for potential antibiotics
has also gained in prominence
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTICS ARE PART OF
BACTERIAL SELF PROTECTION
 Many antibiotics are produced by
microorganisms as part of their survival
mechanism
 They keep other organisms away
 They protect the supply of nutrients and oxygen
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTICS ARE PART OF
BACTERIAL SELF PROTECTION
 Microorganisms that produce these substances
have molecular mechanisms to control
production and prevent self-destruction
 Naturally produced antibiotics are products of
secondary metabolic pathways
 These pathways are not turned on all the time
 Continuous production could adversely affect the
organism
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTICS ARE PART OF
BACTERIAL SELF PROTECTION
 Organisms protect themselves in several ways:
 Some bacteria restrict antibiotic production to the
stationary phase
 Others keep the intracellular concentrations at low
levels

They regulate rates of production and export
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTICS ARE PART OF
BACTERIAL SELF PROTECTION
 Antibiotic molecules are exported in an
inactive form
 They become activated by extracellular enzymes
 Some microorganisms modify their own cell
walls to ensure their safety
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC SPECTRA
 The first molecules that inhibited bacterial
growth were natural products
 Over time, these natural molecules have been
modified
 Several types of semi-synthetic antibiotics
have been derived from these molecules
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC SPECTRA
 Antibiotics are classified as either broad-
spectrum or narrow-spectrum
 The original natural molecules used by
humans as antibiotics have a very narrow
spectrum
 Natural molecules can be chemically modified
making it possible to broaden their spectrum
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC SPECTRA
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
 The structure of penicillin is useful as a
template for the development of an entire
group of antibiotics (more than 50 so far)
 In its native form, penicillin is composed of a
core four-sided ring structure
 The beta (β)-lactam ring
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
 All forms of penicillin contain this ring
 Derivatives contain additional specific
structures:
 Side chains attached to the ring
 Chemically changing the side chain can change:

Antimicrobial activity

Resistance to stomach acid

Overall half-life in body
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
 There are semi-synthetic forms of penicillin
 They are created through modifications that can be
made in a laboratory
 Chemists can create and modify side chains
 This produces new forms of penicillin
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
 Natural penicillin has a very narrow spectrum
 Chemically modifying penicillin broadens the
spectrum
 Semi-synthetic penicillins can be further
modified to increase the efficiency of
inhibiting bacterial growth
 Ampicillin can be modified to mezlocillin or
azlocillin
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC STRUCTURE
 The same kind of manipulation can be seen
with cephalosporin family
 Modification of the natural molecule has resulted
in several generations of semi-synthetics
 Modifications result from changing the side
chains leaving core intact
 Modifications also change reactivity patterns
and spectrum
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC TARGETS
 A fundamental criterion of antibiotics for
medical use is selective toxicity
 The antibiotic should be destructive to the disease-
causing organism but have no effect on the human
host
 The first antibiotic discovered was most
selectively toxic
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC TARGETS
 Many chemicals are useful in restricting
bacterial growth
 They are also inherently toxic
 They cannot be used therapeutically
 Many antibiotic molecules are toxic if
administered at high concentrations
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC TARGETS
 Antibiotic targets can be subdivided into five
major groups:
 The bacterial cell wall
 The bacterial plasma membrane
 Synthesis of bacterial proteins
 Bacterial nucleic acids
 Bacterial metabolism
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIBIOTIC TARGETS
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL
 It is the most appealing target for antibiotics
 Found in bacteria but not humans
 Meets the criterion of selective toxicity
 It is found in both Gram-positive and Gram-
negative bacteria
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL
 The cell wall is built by many enzymatic reactions
 These enzymes can be used as targets of antibiotic
molecules
 The cell wall is made up of the peptidoglycan
molecules NAG and NAM
 They are cross-linked through activity of
transglycosylase and transpeptidase enzymes
 Many antibiotics inhibit the activity of these two
enzymes

Results in improper cell wall cross-linking

Organism is not able to withstand environmental pressures
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Penicillins
 Penicillin-binding proteins (PBPs) are
involved in the construction of the cell wall
 β-lactam ring of penicillin binds to these
proteins
 New cell wall continuously built during active
growth
 Penicillin prevents the formation of an intact cell
wall
 Penicillin is most effective during this phase
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Penicillins
 Gram-negative bacteria have markedly less
peptidoglycan
 They are normally less sensitive to penicillin
 Reactivity of penicillin against Gram-negative
bacteria has been enhanced by synthetically
modifying the core structure
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Cephalosporins
 Cephalosporins have similar activity to
penicillins
 They prevent the construction of a stable cell wall
 Cephalosporins have a much greater effect on
Gram-negative bacteria than penicillins
 They are naturally broader spectrum antibiotics
 They are not susceptible to the β-lactamase
enzymes
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Cephalosporins
 There are multiple generations of
cephalosporins
 More than 70 versions are in use
 They are one of the most widely prescribed
antibiotics
 Mechanism of action similar to that of
penicillin but cephalosporin penetrates through
porin channels
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Cephalosporins
 Side chains can be modified to increase the
spectrum of reactivity
 Cephalosporins are frequently used both
preoperatively and postoperatively
 Frequent use has increased resistance
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Carbapenems
 Carbapenems contain a β-lactam ring like
penicillin
 They also inhibit the synthesis of bacterial walls
 The β-lactam ring of carbapenems contains a
double bond
 This prevents β-lactamase cleaving the ring
 Carbapenems have a very broad spectrum of
antibacterial activity
 Two are approved for clinical use in humans
 Both are useful against Pseudomonas species
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Monobactams
 Monobactams have a different ring structure
 They cannot be recognized by β-lactamase
 They are effective in overcoming bacterial
resistance realted to β-lactamase
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Glycopeptide Antibiotics
 Glycopeptide antibiotics are derived from Streptomyces
organisms
 Vancomycin and teicoplanin are glycopeptide antibiotics
 Glycopeptide antibiotics have serious side effects
 Toxicity level reduced in recent years by improving
purification
 They inhibit cell wall synthesis by forming a complex
with the substrates that make up peptidoglycan
 They cannot penetrate the porins of Gram-negative
cells
 Narrow spectrum antibiotics restricted to Gram-positive
bacteria
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
 These antibiotics are used against bacteria with
modified cell walls
 Mycobacterium species (cause TB and
leprosy) are a good example
 Their cell walls are modified by incorporation of
mycolic acids
 Isoniazid very effective against these
organisms
 Inhibits the synthesis of mycolic acid
BACTERIAL CELL WALL:
Peptide Antibiotics Effective Against Mycobacteria
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Peptide Antibiotics Effective Against Mycobacteria
 Ethambutol is given in concert with isoniazid
 Inhibit the incorporation of mycolic acid into cell
wall
 The treatment of choice for tuberculosis is a
combination of isoniazid, ethambutol, and
rifampin
 Combinations of drugs lower the potential for
development of resistance
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL CELL WALL:
Polypeptide Antibiotics
 Bacitracin and polymixin B
 Used topically for superficial infections by
Gram-positive organisms
 Staphylococcus and Streptococcus
 They inhibit binding between NAG and NAM
 Prevents formation of linear strands of
peptidoglycan
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL PLASMA
MEMBRANE
 The plasma membrane is involved with
important physiological functions
 It is a prime target for antibiotics
 Any disruption of the membrane destroys the
bacteria
 Unfortunately the structure of the bacterial
plasma membrane is similar to the eukaryotic
plasma membrane
 This does not allow for selective toxicity
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS
 Disruption in the production of protein is
devastating to a bacterial cell
 Ribosomes of prokaryotes are not the same as
those in the cytoplasm of eukaryotes
 This allows for selective toxicity
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS
 Eukaryotic cells have mitochondria that
contain ribosomes
 These are the same as the ribosomes in prokaryotic
cells
 There is antibiotic interference in eukaryotic cell
function if antibiotics given in excessive amounts
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS
 Antibiotics act at different sites on bacterial
ribosomes
 Streptomycin targets the 30S subunit
 Chloramphenicol targets the 50S subunit
 Some antibiotics interfere in peptide
elongation
 Some antibiotics interfere with decoding the
message
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS: Macrolides
 Macrolides block elongation of peptide chains
in the 50S subunit
 They include erythromycin, azithromycin, and
clarithromycin
 Narrow spectrum and used only for Gram-positive
infections
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS: Tetracyclines
 Tetracyclines have been used since the late
1940s
 They are bacteriostatic
 They block the arrival of tRNA at the A site
 They have been in use for so long many bacteria
are resistant

Use has steadily declined
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
SYNTHESIS OF BACTERIAL
PROTEINS: Aminoglycosides
 Aminoglycosides have been in use since the
1940s
 They target the 16S RNA portion of the 30S ribosomal
subunit
 Gentamycin and tobramycin are potent against
Gram-negative organisms
 Not very effective against Gram-positive bacteria
 Used in combination with β-lactam antibiotics
 Produce significant renal toxicity and ototoxicity
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL NUCLEIC ACIDS
 DNA and RNA are universal components
 Their structure in bacteria is no different from their
structure in humans
 This does not allow for selective toxicity
 Two families of synthetic compounds can
target bacterial nucleic acids
 Quinolones and rifamycins
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL NUCLEIC ACIDS:
Quinolones
 Quinolones target bacterial topoisomerases
 Bacterial topoisomerases are different to those in
eukaryotic cells
 They are an excellent target
 Block the movement of the replication fork
 Used in the treatment of:

Urinary tract infections

Osteomyelitis

Community-acquired pneumonia and gastroenteritis

Anthrax
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL NUCLEIC ACIDS:
Rifamycins
 Rifamycins bind to RNA polymerase and
prevent it from functioning
 Binding occurs away from the active site
 Blocking RNA polymerase means no protein
synthesis

This is lethal
 Rifampin is the only rifamycin in use

It is used only in combination therapy

Resistance develops rapidly if it is used alone
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL METABOLISM
 Two targets for inhibiting bacterial growth are:
 Production of nucleic acid precursors
 Metabolic pathways that occur at the plasma
membrane
 Several pathways exclusive to bacteria:
 Interruption selectively inhibits bacterial growth
 This allows for selective toxicity
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL METABOLISM:
Folic acid
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL METABOLISM:
Folic acid
 A good example is the metabolism of folic acid
 One of the intermediates in the folic acid pathway
is para-aminobenzoic acid (PABA)
 Normal enzyme action incorporates PABA into the
pathway
 Sulfa drugs competitively inhibit this activity:

The enzyme is fooled into incorporating the sulfa molecule

Incorporation of sulfa stops the pathway

This is a lethal event
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL METABOLISM:
Folic acid
 Action against the folic acid pathway has
selective toxicity
 Bacteria synthesize folic acid
 Humans obtain folic acid through diet
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
BACTERIAL METABOLISM:
Folic acid
 Sulfa drugs have been in use longer than any
other antibacterial agent
 Sulfamethoxazole is usually used in combination
with trimethoprim to treat urinary tract infections
 Both of these drugs block a step in folic acid
metabolism
 These drugs been used for a long time

Bacterial resistance continues to increase

Their effectiveness continues to decrease
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIVIRAL DRUGS
 Viruses pose a different set of problems for
antibiotic therapy
 They are obligate intracellular parasites
 Drugs that can eliminate the virus are dangerous to
non-infected cells
 This makes selective toxicity difficult
 Many viruses difficult to grow
 It is difficult to test potential antiviral drugs
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIVIRAL DRUGS
 The lack of rapid tests means it is difficult to
differentiate between various viral infections
 Successful antiviral drugs must eliminate all
virions
 The escape of even one virion could restart the
infectious cycle
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIVIRAL DRUGS
 The first antibiotic to be used against viruses
was the sulfa drug derivative
thiosemicarbazone
 Molecular techniques are now used to develop
antiviral drugs
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
NUCLEOSIDE ANALOGS :
Acyclovir
 Acyclovir is a nucleoside analog of guanine
produced as a prodrug
 It is activated by enzymes once in the patient’s body
 These enzymes are found only in infected cells
 Acyclovir has selective toxicity
 It works by blockade and termination of viral
DNA replication
 New variations (Valtrex®
and Famvir®
) are very
effective and widely used
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
NUCLEOSIDE ANALOGS:
Acyclovir
 Acyclovir is a specific and nontoxic drug
 It is highly effective against both genital and
oral herpes simplex infections
 Also been used with some success in treatment of
varicella-zoster (chickenpox and shingles)
 It can be taken intravenously or orally or used
topically
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
NUCLEOSIDE ANALOGS:
AZT
 Azidothymidine is a nucleoside analog
 It is used in the treatment of HIV
 It inhibits reverse transcriptase
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
NUCLEOTIDE ANALOGS
 Similar to nucleoside analogs
 Do not require initial activation step
 Cidofovir is effective against a number of
viruses, including cytomegalovirus,
papillomavirus, herpesvirus, and poxvirus
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
NON-NUCLEOSIDE INHIBITORS
 Allosteric inhibitors of DNA polymerase
 Foscarnet is effective against herpesvirus and
HIV
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
INHIBITING VIRALASSEMBLY
AND RELEASE:
Protease Inhibitors
 Inhibit viral protease and interfere with
assembly of virions
 Saquinavir and ritonavir, used for HIV
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
INHIBITING VIRALASSEMBLY
AND RELEASE:
Neuraminidase Inhibitors
 Target the neuraminidase proteins of influenza
 Prevent budding of virions from host cell
 Examples are zanamivir and oseltamivir
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
INHIBITING VIRAL
UNCOATING
 Binds a viral protein and inhibits uncoating
 Amantadine was used against influenza
 Influenza strains are now resistant to
amantadine
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
INHIBITING VIRAL ENTRY
 An exciting area of research and development
 Focused on small molecules that inhibit one of
the proteins the virus uses to fuse with plasma
membranes
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
DRACO
 Double-stranded RNAActivated Caspase
Oligomerizer
 Potentially effective against many infectious
viruses
 Causes apoptosis in infected cells, but leaves
uninfected cells unharmed
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIFUNGAL DRUGS:
Polyenes
 Polyenes are produced by the soil bacterium
Streptomyces
 They interact with sterols and increase the
permeability of the plasma membrane
 They must be used with caution because of
side effects
 Amphotericin B has high renal toxicity
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIFUNGAL DRUGS:
Azoles
 Azoles (imidazole and triazole) inhibit the
production of ergosterol
 Clotrimazole and miconazole are derivatives
of imidazole
 Sold without a prescription
 Routinely used topically against athlete’s foot and
vaginal yeast infection
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIFUNGAL DRUGS:
Azoles
 Ketoconazole is a broad spectrum derivative
used for systemic fungal infections
 Can be taken orally
 Less toxic than amphotericin B
 Fluconazole and itraconazole are the least
toxic azoles
 Widely used for systemic fungal infections
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTIFUNGAL DRUGS:
Other Antifungals
 Echinocandins inhibit glucan synthesis
 Narrow spectrum and very specific
 Flucytosine interferes with DNA and RNA
synthesis
 It is taken up preferentially by fungi
 Has a high level of toxicity in kidney and bone
marrow
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
DRUGS FOR PARASITIC
INFECTIONS
 The development of drugs for parasitic
infections has lagged behind, because:
 Parasitic infections do not occur often in
developed nations
 There was no money to be made
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTI-PROTOZOAN DRUGS:
Antimalarials
 Quinine has been used as a treatment for
malaria since the 1600s
 It has been chemically modified into several
synthetic forms
 Chloroquine and mefloquine have been widely
used
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTI-PROTOZOAN DRUGS :
Antimalarials
 Another quinine derivative:

Diiodohydroxyquin

Used for treatment of intestinal amebic disease

Found to be toxic to the optic nerve
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTI-PROTOZOAN DRUGS :
Antimalarials
 Plasmodium develops resistance to many
antimalarial drugs
 Artemisinin, primaquine, and quinacrine are
more recently developed antimalarials
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTI-PROTOZOAN DRUGS :
Folate Agonists
 Disrupt folic acid metabolism and block
nucleic acid synthesis and repair
 Pyrimethamine and proquanil are antimalarial
and used to treat toxoplasmosis
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
 Metronidazole is one of the most widely used
anti-protozoan drugs
 Sold under the name Flagyl®
 It is the drug of choice for:
 Vaginitis resulting from Trichomonas vaginalis
 Giardiasis
 Amebic dysentery
 Clostridium difficile
ANTI-PROTOZOAN DRUGS :
Drugs for Anaerobic Protozoa
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
 Metronidazole and iodoquinol used to treat
amebiasis caused by Entamoeba histolytica
ANTI-PROTOZOAN DRUGS :
Drugs for Anaerobic Protozoa
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
 Eflornithine has greatly reduced infection by
Trypanosoma bruceii (cause of African
sleeping sickness)
 Melarsoprol is used to treat African sleeping
sickness and Chagas’ disease
 Sodium stibogluconate is used to treat
leishmaniasis
ANTI-PROTOZOAN DRUGS :
Drugs for Trypanosoma and Leishmania
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTHELMINTHICS
 Anti-helminthic drugs have also been largely
ignored until recently
 Affected populations were not found in developed
countrie
 The popularity of sushi has led to an increase in
tapeworm infestations
 Increased world travel has also increased helminth
infections
ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd
Edition) © Garland Science
ANTHELMINTHICS :
Nematodes
 Ivermectin is used for a wide variety of
internal nematode infections
 Piperazine and tetrahydropyrimidine are also
used for nematode infections

More Related Content

What's hot

BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCEBIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
Shedrick Charles Nyangiti
 
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
Rameshjoshi66
 

What's hot (20)

Timeline of Biotech development from 2003 to 2017
Timeline of Biotech development from 2003 to 2017Timeline of Biotech development from 2003 to 2017
Timeline of Biotech development from 2003 to 2017
 
Misuse of-antibiotics
Misuse of-antibioticsMisuse of-antibiotics
Misuse of-antibiotics
 
Biotechnology ppt by anila rani pullagura
Biotechnology ppt by anila rani pullaguraBiotechnology ppt by anila rani pullagura
Biotechnology ppt by anila rani pullagura
 
Biotechnology and their Applications
Biotechnology and their ApplicationsBiotechnology and their Applications
Biotechnology and their Applications
 
CHOOSING THE RIGHT ANTIBIOTIC ? Need for Antibiotic Policy
CHOOSING THE RIGHT ANTIBIOTIC ?Need for Antibiotic Policy         CHOOSING THE RIGHT ANTIBIOTIC ?Need for Antibiotic Policy
CHOOSING THE RIGHT ANTIBIOTIC ? Need for Antibiotic Policy
 
Application of Biotechnology In Medicine By Anila Rani Pullagura
Application of Biotechnology In Medicine By Anila Rani PullaguraApplication of Biotechnology In Medicine By Anila Rani Pullagura
Application of Biotechnology In Medicine By Anila Rani Pullagura
 
Synthetic biology
Synthetic biologySynthetic biology
Synthetic biology
 
Curing human diseases using microorganisms
Curing human diseases using microorganismsCuring human diseases using microorganisms
Curing human diseases using microorganisms
 
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCEBIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
BIOTECHNOLOGY AND ITS APPLICATION TO VETERINARY SCIENCE
 
Akash jadhav ppt.
Akash jadhav ppt.Akash jadhav ppt.
Akash jadhav ppt.
 
CONCEPT AND SCOPE OF BIOTECHNOLOGY BY AARIF
CONCEPT AND SCOPE OF BIOTECHNOLOGY BY AARIFCONCEPT AND SCOPE OF BIOTECHNOLOGY BY AARIF
CONCEPT AND SCOPE OF BIOTECHNOLOGY BY AARIF
 
Recent advances in biotechnology
Recent advances in biotechnologyRecent advances in biotechnology
Recent advances in biotechnology
 
Biotechnology in medicine
Biotechnology in medicine Biotechnology in medicine
Biotechnology in medicine
 
Functional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology IndustryFunctional Overview of the Biotechnology Industry
Functional Overview of the Biotechnology Industry
 
Introduction to pharmaceutical biotechnology as per PCI syllabus
Introduction to pharmaceutical biotechnology as per PCI syllabusIntroduction to pharmaceutical biotechnology as per PCI syllabus
Introduction to pharmaceutical biotechnology as per PCI syllabus
 
Unit1 biotechnology timeline
Unit1 biotechnology timelineUnit1 biotechnology timeline
Unit1 biotechnology timeline
 
Medical biotechnology ch.11
Medical biotechnology  ch.11Medical biotechnology  ch.11
Medical biotechnology ch.11
 
Pharmaceutical Biotechnology
Pharmaceutical BiotechnologyPharmaceutical Biotechnology
Pharmaceutical Biotechnology
 
Medical Biotechnology and Genetics Journal - SciDocPublishers
Medical Biotechnology and Genetics Journal - SciDocPublishersMedical Biotechnology and Genetics Journal - SciDocPublishers
Medical Biotechnology and Genetics Journal - SciDocPublishers
 
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
Coccidiosis in poultry anticoccidial products vaccines and other prevention s...
 

Similar to Ch. 19 Antibiotics and Antimicrobials

ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
Esam Yahya
 
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
BRNSS Publication Hub
 
The Role of Antibiotics and Antibiotic Resistance in Nature
The Role of Antibiotics and Antibiotic Resistance in NatureThe Role of Antibiotics and Antibiotic Resistance in Nature
The Role of Antibiotics and Antibiotic Resistance in Nature
ijtsrd
 
Modes of action and resistance mechanisms of commonly used antibioticsa
Modes of action and resistance mechanisms of commonly used antibioticsaModes of action and resistance mechanisms of commonly used antibioticsa
Modes of action and resistance mechanisms of commonly used antibioticsa
Muhanna Al-shaibani
 
Antibiotic Resistance
Antibiotic ResistanceAntibiotic Resistance
Antibiotic Resistance
SayantanDas85
 

Similar to Ch. 19 Antibiotics and Antimicrobials (20)

Ch 4 Cell Structure
Ch 4 Cell StructureCh 4 Cell Structure
Ch 4 Cell Structure
 
Chapter 18 Control of Microbial Growth/Disinfectants/Aseptics
Chapter 18 Control of Microbial Growth/Disinfectants/AsepticsChapter 18 Control of Microbial Growth/Disinfectants/Aseptics
Chapter 18 Control of Microbial Growth/Disinfectants/Aseptics
 
Lecture Chapter 1 2e
Lecture Chapter 1 2eLecture Chapter 1 2e
Lecture Chapter 1 2e
 
Lecture chapter 10
Lecture chapter 10Lecture chapter 10
Lecture chapter 10
 
Lecture chapter 05
Lecture chapter 05Lecture chapter 05
Lecture chapter 05
 
Chloramphenicol Essay
Chloramphenicol EssayChloramphenicol Essay
Chloramphenicol Essay
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
 
Ch. 21 Infections of the Respiratory System
Ch. 21 Infections of the Respiratory SystemCh. 21 Infections of the Respiratory System
Ch. 21 Infections of the Respiratory System
 
Ajbsr.ms.id.001181
Ajbsr.ms.id.001181Ajbsr.ms.id.001181
Ajbsr.ms.id.001181
 
Antibiotics Lecture 01
Antibiotics Lecture 01Antibiotics Lecture 01
Antibiotics Lecture 01
 
Xeraya & Allecra: The Fight Against Gram-Negative Drug-Resistant Bacteria (Hi...
Xeraya & Allecra: The Fight Against Gram-Negative Drug-Resistant Bacteria (Hi...Xeraya & Allecra: The Fight Against Gram-Negative Drug-Resistant Bacteria (Hi...
Xeraya & Allecra: The Fight Against Gram-Negative Drug-Resistant Bacteria (Hi...
 
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
A Review on Antibacterial Phytochemical Constitutions Present in Aerva lanata...
 
Antibiotic resistance
Antibiotic resistanceAntibiotic resistance
Antibiotic resistance
 
The Role of Antibiotics and Antibiotic Resistance in Nature
The Role of Antibiotics and Antibiotic Resistance in NatureThe Role of Antibiotics and Antibiotic Resistance in Nature
The Role of Antibiotics and Antibiotic Resistance in Nature
 
1 st unit antibiotics
1 st unit antibiotics1 st unit antibiotics
1 st unit antibiotics
 
Modes of action and resistance mechanisms of commonly used antibioticsa
Modes of action and resistance mechanisms of commonly used antibioticsaModes of action and resistance mechanisms of commonly used antibioticsa
Modes of action and resistance mechanisms of commonly used antibioticsa
 
A report on Antibiotics
A report on AntibioticsA report on Antibiotics
A report on Antibiotics
 
Introduction to Drug Target Identification
Introduction to Drug Target IdentificationIntroduction to Drug Target Identification
Introduction to Drug Target Identification
 
Antibiotic Resistance
Antibiotic ResistanceAntibiotic Resistance
Antibiotic Resistance
 
idr-11-2018.pdf
idr-11-2018.pdfidr-11-2018.pdf
idr-11-2018.pdf
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 

Recently uploaded (20)

Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 

Ch. 19 Antibiotics and Antimicrobials

  • 1. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science CHAPTER 19 ANTIBIOTICS AND ANTIMICROBIAL DRUGS
  • 2. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science WHY IS THIS IMPORTANT?  Antibiotics have drastically reduced the number of deaths due to infection  They have changed the face of health care
  • 3. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science OVERVIEW
  • 4. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SOURCE OF ANTIBIOTICS  The discovery of the first antibiotic was an accident  Alexander Fleming accidentally contaminated a plate with a fungus  He observed a clearly defined region of no bacterial growth where the fungi had contaminated the plate  The area around the fungus was eventually referred to as a zone of inhibition
  • 5. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SOURCE OF ANTIBIOTICS  It is estimated that over 80 million prescriptions are written in America each year  12,500 tons of antibiotics are produced annually  From 1900 to 1980, mortality from infectious diseases dropped from 797 per 100,000 persons to 36 per 100,000 persons
  • 6. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science HISTORICAL PERSPECTIVES
  • 7. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science HISTORICAL PERSPECTIVES  Few major discoveries of natural antibiotic substances have occurred for several years  Efforts have now shifted to modifying existing antibiotics  Searching in new places for potential antibiotics has also gained in prominence
  • 8. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTICS ARE PART OF BACTERIAL SELF PROTECTION  Many antibiotics are produced by microorganisms as part of their survival mechanism  They keep other organisms away  They protect the supply of nutrients and oxygen
  • 9. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTICS ARE PART OF BACTERIAL SELF PROTECTION  Microorganisms that produce these substances have molecular mechanisms to control production and prevent self-destruction  Naturally produced antibiotics are products of secondary metabolic pathways  These pathways are not turned on all the time  Continuous production could adversely affect the organism
  • 10. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTICS ARE PART OF BACTERIAL SELF PROTECTION  Organisms protect themselves in several ways:  Some bacteria restrict antibiotic production to the stationary phase  Others keep the intracellular concentrations at low levels  They regulate rates of production and export
  • 11. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTICS ARE PART OF BACTERIAL SELF PROTECTION  Antibiotic molecules are exported in an inactive form  They become activated by extracellular enzymes  Some microorganisms modify their own cell walls to ensure their safety
  • 12. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC SPECTRA  The first molecules that inhibited bacterial growth were natural products  Over time, these natural molecules have been modified  Several types of semi-synthetic antibiotics have been derived from these molecules
  • 13. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC SPECTRA  Antibiotics are classified as either broad- spectrum or narrow-spectrum  The original natural molecules used by humans as antibiotics have a very narrow spectrum  Natural molecules can be chemically modified making it possible to broaden their spectrum
  • 14. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC SPECTRA
  • 15. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE  The structure of penicillin is useful as a template for the development of an entire group of antibiotics (more than 50 so far)  In its native form, penicillin is composed of a core four-sided ring structure  The beta (β)-lactam ring
  • 16. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE
  • 17. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE  All forms of penicillin contain this ring  Derivatives contain additional specific structures:  Side chains attached to the ring  Chemically changing the side chain can change:  Antimicrobial activity  Resistance to stomach acid  Overall half-life in body
  • 18. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE  There are semi-synthetic forms of penicillin  They are created through modifications that can be made in a laboratory  Chemists can create and modify side chains  This produces new forms of penicillin
  • 19. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE  Natural penicillin has a very narrow spectrum  Chemically modifying penicillin broadens the spectrum  Semi-synthetic penicillins can be further modified to increase the efficiency of inhibiting bacterial growth  Ampicillin can be modified to mezlocillin or azlocillin
  • 20. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC STRUCTURE  The same kind of manipulation can be seen with cephalosporin family  Modification of the natural molecule has resulted in several generations of semi-synthetics  Modifications result from changing the side chains leaving core intact  Modifications also change reactivity patterns and spectrum
  • 21. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC TARGETS  A fundamental criterion of antibiotics for medical use is selective toxicity  The antibiotic should be destructive to the disease- causing organism but have no effect on the human host  The first antibiotic discovered was most selectively toxic
  • 22. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC TARGETS  Many chemicals are useful in restricting bacterial growth  They are also inherently toxic  They cannot be used therapeutically  Many antibiotic molecules are toxic if administered at high concentrations
  • 23. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC TARGETS  Antibiotic targets can be subdivided into five major groups:  The bacterial cell wall  The bacterial plasma membrane  Synthesis of bacterial proteins  Bacterial nucleic acids  Bacterial metabolism
  • 24. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIBIOTIC TARGETS
  • 25. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL  It is the most appealing target for antibiotics  Found in bacteria but not humans  Meets the criterion of selective toxicity  It is found in both Gram-positive and Gram- negative bacteria
  • 26. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL  The cell wall is built by many enzymatic reactions  These enzymes can be used as targets of antibiotic molecules  The cell wall is made up of the peptidoglycan molecules NAG and NAM  They are cross-linked through activity of transglycosylase and transpeptidase enzymes  Many antibiotics inhibit the activity of these two enzymes  Results in improper cell wall cross-linking  Organism is not able to withstand environmental pressures
  • 27. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Penicillins  Penicillin-binding proteins (PBPs) are involved in the construction of the cell wall  β-lactam ring of penicillin binds to these proteins  New cell wall continuously built during active growth  Penicillin prevents the formation of an intact cell wall  Penicillin is most effective during this phase
  • 28. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Penicillins  Gram-negative bacteria have markedly less peptidoglycan  They are normally less sensitive to penicillin  Reactivity of penicillin against Gram-negative bacteria has been enhanced by synthetically modifying the core structure
  • 29. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Cephalosporins  Cephalosporins have similar activity to penicillins  They prevent the construction of a stable cell wall  Cephalosporins have a much greater effect on Gram-negative bacteria than penicillins  They are naturally broader spectrum antibiotics  They are not susceptible to the β-lactamase enzymes
  • 30. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Cephalosporins  There are multiple generations of cephalosporins  More than 70 versions are in use  They are one of the most widely prescribed antibiotics  Mechanism of action similar to that of penicillin but cephalosporin penetrates through porin channels
  • 31. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Cephalosporins  Side chains can be modified to increase the spectrum of reactivity  Cephalosporins are frequently used both preoperatively and postoperatively  Frequent use has increased resistance
  • 32. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Carbapenems  Carbapenems contain a β-lactam ring like penicillin  They also inhibit the synthesis of bacterial walls  The β-lactam ring of carbapenems contains a double bond  This prevents β-lactamase cleaving the ring  Carbapenems have a very broad spectrum of antibacterial activity  Two are approved for clinical use in humans  Both are useful against Pseudomonas species
  • 33. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Monobactams  Monobactams have a different ring structure  They cannot be recognized by β-lactamase  They are effective in overcoming bacterial resistance realted to β-lactamase
  • 34. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Glycopeptide Antibiotics  Glycopeptide antibiotics are derived from Streptomyces organisms  Vancomycin and teicoplanin are glycopeptide antibiotics  Glycopeptide antibiotics have serious side effects  Toxicity level reduced in recent years by improving purification  They inhibit cell wall synthesis by forming a complex with the substrates that make up peptidoglycan  They cannot penetrate the porins of Gram-negative cells  Narrow spectrum antibiotics restricted to Gram-positive bacteria
  • 35. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science  These antibiotics are used against bacteria with modified cell walls  Mycobacterium species (cause TB and leprosy) are a good example  Their cell walls are modified by incorporation of mycolic acids  Isoniazid very effective against these organisms  Inhibits the synthesis of mycolic acid BACTERIAL CELL WALL: Peptide Antibiotics Effective Against Mycobacteria
  • 36. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Peptide Antibiotics Effective Against Mycobacteria  Ethambutol is given in concert with isoniazid  Inhibit the incorporation of mycolic acid into cell wall  The treatment of choice for tuberculosis is a combination of isoniazid, ethambutol, and rifampin  Combinations of drugs lower the potential for development of resistance
  • 37. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL CELL WALL: Polypeptide Antibiotics  Bacitracin and polymixin B  Used topically for superficial infections by Gram-positive organisms  Staphylococcus and Streptococcus  They inhibit binding between NAG and NAM  Prevents formation of linear strands of peptidoglycan
  • 38. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL PLASMA MEMBRANE  The plasma membrane is involved with important physiological functions  It is a prime target for antibiotics  Any disruption of the membrane destroys the bacteria  Unfortunately the structure of the bacterial plasma membrane is similar to the eukaryotic plasma membrane  This does not allow for selective toxicity
  • 39. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS  Disruption in the production of protein is devastating to a bacterial cell  Ribosomes of prokaryotes are not the same as those in the cytoplasm of eukaryotes  This allows for selective toxicity
  • 40. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS  Eukaryotic cells have mitochondria that contain ribosomes  These are the same as the ribosomes in prokaryotic cells  There is antibiotic interference in eukaryotic cell function if antibiotics given in excessive amounts
  • 41. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS  Antibiotics act at different sites on bacterial ribosomes  Streptomycin targets the 30S subunit  Chloramphenicol targets the 50S subunit  Some antibiotics interfere in peptide elongation  Some antibiotics interfere with decoding the message
  • 42. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS: Macrolides  Macrolides block elongation of peptide chains in the 50S subunit  They include erythromycin, azithromycin, and clarithromycin  Narrow spectrum and used only for Gram-positive infections
  • 43. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS: Tetracyclines  Tetracyclines have been used since the late 1940s  They are bacteriostatic  They block the arrival of tRNA at the A site  They have been in use for so long many bacteria are resistant  Use has steadily declined
  • 44. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science SYNTHESIS OF BACTERIAL PROTEINS: Aminoglycosides  Aminoglycosides have been in use since the 1940s  They target the 16S RNA portion of the 30S ribosomal subunit  Gentamycin and tobramycin are potent against Gram-negative organisms  Not very effective against Gram-positive bacteria  Used in combination with β-lactam antibiotics  Produce significant renal toxicity and ototoxicity
  • 45. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL NUCLEIC ACIDS  DNA and RNA are universal components  Their structure in bacteria is no different from their structure in humans  This does not allow for selective toxicity  Two families of synthetic compounds can target bacterial nucleic acids  Quinolones and rifamycins
  • 46. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL NUCLEIC ACIDS: Quinolones  Quinolones target bacterial topoisomerases  Bacterial topoisomerases are different to those in eukaryotic cells  They are an excellent target  Block the movement of the replication fork  Used in the treatment of:  Urinary tract infections  Osteomyelitis  Community-acquired pneumonia and gastroenteritis  Anthrax
  • 47. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL NUCLEIC ACIDS: Rifamycins  Rifamycins bind to RNA polymerase and prevent it from functioning  Binding occurs away from the active site  Blocking RNA polymerase means no protein synthesis  This is lethal  Rifampin is the only rifamycin in use  It is used only in combination therapy  Resistance develops rapidly if it is used alone
  • 48. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL METABOLISM  Two targets for inhibiting bacterial growth are:  Production of nucleic acid precursors  Metabolic pathways that occur at the plasma membrane  Several pathways exclusive to bacteria:  Interruption selectively inhibits bacterial growth  This allows for selective toxicity
  • 49. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL METABOLISM: Folic acid
  • 50. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL METABOLISM: Folic acid  A good example is the metabolism of folic acid  One of the intermediates in the folic acid pathway is para-aminobenzoic acid (PABA)  Normal enzyme action incorporates PABA into the pathway  Sulfa drugs competitively inhibit this activity:  The enzyme is fooled into incorporating the sulfa molecule  Incorporation of sulfa stops the pathway  This is a lethal event
  • 51. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL METABOLISM: Folic acid  Action against the folic acid pathway has selective toxicity  Bacteria synthesize folic acid  Humans obtain folic acid through diet
  • 52. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science BACTERIAL METABOLISM: Folic acid  Sulfa drugs have been in use longer than any other antibacterial agent  Sulfamethoxazole is usually used in combination with trimethoprim to treat urinary tract infections  Both of these drugs block a step in folic acid metabolism  These drugs been used for a long time  Bacterial resistance continues to increase  Their effectiveness continues to decrease
  • 53. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIVIRAL DRUGS  Viruses pose a different set of problems for antibiotic therapy  They are obligate intracellular parasites  Drugs that can eliminate the virus are dangerous to non-infected cells  This makes selective toxicity difficult  Many viruses difficult to grow  It is difficult to test potential antiviral drugs
  • 54. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIVIRAL DRUGS  The lack of rapid tests means it is difficult to differentiate between various viral infections  Successful antiviral drugs must eliminate all virions  The escape of even one virion could restart the infectious cycle
  • 55. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIVIRAL DRUGS  The first antibiotic to be used against viruses was the sulfa drug derivative thiosemicarbazone  Molecular techniques are now used to develop antiviral drugs
  • 56. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science NUCLEOSIDE ANALOGS : Acyclovir  Acyclovir is a nucleoside analog of guanine produced as a prodrug  It is activated by enzymes once in the patient’s body  These enzymes are found only in infected cells  Acyclovir has selective toxicity  It works by blockade and termination of viral DNA replication  New variations (Valtrex® and Famvir® ) are very effective and widely used
  • 57. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science NUCLEOSIDE ANALOGS: Acyclovir  Acyclovir is a specific and nontoxic drug  It is highly effective against both genital and oral herpes simplex infections  Also been used with some success in treatment of varicella-zoster (chickenpox and shingles)  It can be taken intravenously or orally or used topically
  • 58. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science NUCLEOSIDE ANALOGS: AZT  Azidothymidine is a nucleoside analog  It is used in the treatment of HIV  It inhibits reverse transcriptase
  • 59. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science NUCLEOTIDE ANALOGS  Similar to nucleoside analogs  Do not require initial activation step  Cidofovir is effective against a number of viruses, including cytomegalovirus, papillomavirus, herpesvirus, and poxvirus
  • 60. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science NON-NUCLEOSIDE INHIBITORS  Allosteric inhibitors of DNA polymerase  Foscarnet is effective against herpesvirus and HIV
  • 61. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science INHIBITING VIRALASSEMBLY AND RELEASE: Protease Inhibitors  Inhibit viral protease and interfere with assembly of virions  Saquinavir and ritonavir, used for HIV
  • 62. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science INHIBITING VIRALASSEMBLY AND RELEASE: Neuraminidase Inhibitors  Target the neuraminidase proteins of influenza  Prevent budding of virions from host cell  Examples are zanamivir and oseltamivir
  • 63. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science INHIBITING VIRAL UNCOATING  Binds a viral protein and inhibits uncoating  Amantadine was used against influenza  Influenza strains are now resistant to amantadine
  • 64. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science INHIBITING VIRAL ENTRY  An exciting area of research and development  Focused on small molecules that inhibit one of the proteins the virus uses to fuse with plasma membranes
  • 65. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science DRACO  Double-stranded RNAActivated Caspase Oligomerizer  Potentially effective against many infectious viruses  Causes apoptosis in infected cells, but leaves uninfected cells unharmed
  • 66. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIFUNGAL DRUGS: Polyenes  Polyenes are produced by the soil bacterium Streptomyces  They interact with sterols and increase the permeability of the plasma membrane  They must be used with caution because of side effects  Amphotericin B has high renal toxicity
  • 67. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIFUNGAL DRUGS: Azoles  Azoles (imidazole and triazole) inhibit the production of ergosterol  Clotrimazole and miconazole are derivatives of imidazole  Sold without a prescription  Routinely used topically against athlete’s foot and vaginal yeast infection
  • 68. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIFUNGAL DRUGS: Azoles  Ketoconazole is a broad spectrum derivative used for systemic fungal infections  Can be taken orally  Less toxic than amphotericin B  Fluconazole and itraconazole are the least toxic azoles  Widely used for systemic fungal infections
  • 69. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTIFUNGAL DRUGS: Other Antifungals  Echinocandins inhibit glucan synthesis  Narrow spectrum and very specific  Flucytosine interferes with DNA and RNA synthesis  It is taken up preferentially by fungi  Has a high level of toxicity in kidney and bone marrow
  • 70. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science DRUGS FOR PARASITIC INFECTIONS  The development of drugs for parasitic infections has lagged behind, because:  Parasitic infections do not occur often in developed nations  There was no money to be made
  • 71. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTI-PROTOZOAN DRUGS: Antimalarials  Quinine has been used as a treatment for malaria since the 1600s  It has been chemically modified into several synthetic forms  Chloroquine and mefloquine have been widely used
  • 72. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTI-PROTOZOAN DRUGS : Antimalarials  Another quinine derivative:  Diiodohydroxyquin  Used for treatment of intestinal amebic disease  Found to be toxic to the optic nerve
  • 73. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTI-PROTOZOAN DRUGS : Antimalarials  Plasmodium develops resistance to many antimalarial drugs  Artemisinin, primaquine, and quinacrine are more recently developed antimalarials
  • 74. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTI-PROTOZOAN DRUGS : Folate Agonists  Disrupt folic acid metabolism and block nucleic acid synthesis and repair  Pyrimethamine and proquanil are antimalarial and used to treat toxoplasmosis
  • 75. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science  Metronidazole is one of the most widely used anti-protozoan drugs  Sold under the name Flagyl®  It is the drug of choice for:  Vaginitis resulting from Trichomonas vaginalis  Giardiasis  Amebic dysentery  Clostridium difficile ANTI-PROTOZOAN DRUGS : Drugs for Anaerobic Protozoa
  • 76. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science  Metronidazole and iodoquinol used to treat amebiasis caused by Entamoeba histolytica ANTI-PROTOZOAN DRUGS : Drugs for Anaerobic Protozoa
  • 77. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science  Eflornithine has greatly reduced infection by Trypanosoma bruceii (cause of African sleeping sickness)  Melarsoprol is used to treat African sleeping sickness and Chagas’ disease  Sodium stibogluconate is used to treat leishmaniasis ANTI-PROTOZOAN DRUGS : Drugs for Trypanosoma and Leishmania
  • 78. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTHELMINTHICS  Anti-helminthic drugs have also been largely ignored until recently  Affected populations were not found in developed countrie  The popularity of sushi has led to an increase in tapeworm infestations  Increased world travel has also increased helminth infections
  • 79. ISBN: 978-0-8153-6514-3Microbiology: A Clinical Approach, by Tony Srelkauskas © Garland ScienceMicrobiology: A Clinical Approach (2nd Edition) © Garland Science ANTHELMINTHICS : Nematodes  Ivermectin is used for a wide variety of internal nematode infections  Piperazine and tetrahydropyrimidine are also used for nematode infections